Laurus Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CARBOPLATIN USP DRUG SUBSTANCE, with a corresponding US DMF Number 21918.
Remarkably, this DMF maintains an Active status since its submission on August 29, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 17, 2013, and payment made on April 08, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II